|
Related Companies
|
[]
|
||||||||
|
Related Funds
|
[]
|
||||||||
|
|
|||||||||
|
English
|
|||||||||
|
oda_ForwardLookingEvaluationsAbstract|
|
|
||||||||
|
oda_UpdateAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_CorrectionAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_DateOfThePreviousNotificationAboutTheSameSubject|
|
|
-
|
|||||||
|
oda_DelayedAnnouncementFlag|
|
|
Hayır (No)
|
|||||||
|
oda_AnnouncementContentSection|
|
|
||||||||
|
oda_ExplanationSection|
|
|
||||||||
|
oda_ExplanationTextBlock|
|
2021 expectations are given below; Med Complex Margin Med Complex Refining Margin expectation is 0.0 – 0.5 $/bbl Tüpraş Net Margin Tüpraş Net Refining Margin expectation is 2.5 – 3.5 $/bbl Operational Targets Capacity utilization: 90-95% Production: ~ 26-27 million tons Total Sales: ~26-27 million tons Investments Total investments expectation is ~200 Million $ In case of a discrepancy between the Turkish and the English versions of this disclosure, the Turkish version shall prevail.
|
||||||||